Cue Biopharma
75 hedge funds and large institutions have $32.2M invested in Cue Biopharma in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 15 reducing their positions, and 13 closing their positions.
Holders
75
Holders Change
-3
Holders Change %
-3.85%
% of All Funds
1.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
25
Reduced
15
Closed
13
Calls
$240K
Puts
$98K
Net Calls
+$142K
Net Calls Change
-$333K
Top Buyers
| 1 |
SMH
1
Sanders Morris Harris
Houston,
Texas
|
$713K |
| 2 |
2
Millennium Management
New York
|
$722K |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$4.89M |
| 4 |
4
BlackRock
New York
|
$4.9M |
| 5 |
XT
5
XTX Topco
George Town,
Cayman Islands
|
$123K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SCM
76
Silverarc Capital Management
Boston,
Massachusetts
| – | – | -403,402 | Closed |
|
|
JF
77
Jump Financial
Chicago,
Illinois
| – | – | -42,900 | Closed |
|
|
OQS
78
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
| – | – | -37,762 | Closed |
|
79
D.E. Shaw & Co
New York
| – | – | -36,681 | Closed |
|
80
Two Sigma Advisers
New York
| – | – | -27,100 | Closed |
|
81
Mirae Asset Global Investments
Seoul,
South Korea
| – | – | -21,036 | Closed |
|
82
Verition Fund Management
Greenwich,
Connecticut
| – | – | -21,001 | Closed |
|
|
MIM
83
MetLife Investment Management
Whippany,
New Jersey
| – | – | -18,510 | Closed |
|
|
GCP
84
GSA Capital Partners
London,
United Kingdom
| – | – | -18,269 | Closed |
|
|
VF
85
Virtu Financial
New York
| – | – | -17,594 | Closed |
|
86
Two Sigma Investments
New York
| – | – | -14,076 | Closed |
|
|
AG
87
Algert Global
San Francisco,
California
| – | – | -13,230 | Closed |
|
|
MLICM
88
Metropolitan Life Insurance Company (MetLife)
New York
| – | – | -1,918 | Closed |
|
|
CFGS
89
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|